[2] That's when insulin therapy can help. Because of such myths and misconceptions, patients avoid starting insulin therapy. Insulin is a medication that works with other treatments to keep blood ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Just 75 days after the transplant, the patient no longer needed insulin injections. The breakthrough, published in the ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

Hybrid closed-loop insulin therapy prevents low night-time blood glucose levels among breastfeeding mothers with type 1 ...

At a meeting of the Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee, the majority of panel members voted against the approval of sotagliflozin (Zynquista™) ...

“These results support the continued investigation of intranasal insulin and empagliflozin combination therapy for AD,” they ...

This hindrance in leptin delivery poses a challenge to using this adipokine as a potential therapy for obesity ... to ...

As per a report by Livescience, the team extracted fat cells from a woman with type 1 diabetes and chemically reverted these ...

Reproductive dysfunction is a common & less studied complication of Diabetes Mellitus (DM). It’s seen in 40% of women with DM ...

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

PharmaSens announced today that it appointed Dr. Robert A. Gabbay and James L. Peterson to its board of directors.